• You need to sign in or sign up before continuing.
Close
Announcements
Projects
Orgs
Project Post
Articles 130
Votes 0
Endpoints News
Articles
130
FDA approves Vertex and CRISPR's Casgevy as first CRISPR-edited therapy for beta-thalassemia - Endpoints News
>1y
Doudna's new venture; Aclaris CEO to step down; Tome's $114M liver disorder deal with Genevant - Endpoints News
>1y
The Bell Labs of biotech: Stuart Schreiber has billionaire support for new biomedical institute - Endpoints News
>1y
Novartis doubles down on neurologic gene therapy work with Voyager - Endpoints News
>1y
Grail has big plans for its blood cancer tests. The first step: Finding a new owner - Endpoints News
>1y
Lilly, Novo's bet on heart disease starts to take shape, and 2024 could be a pivotal year for their GLP-1s - Endpoints News
>1y